共 114 条
[1]
Mohr I(2019)Biochemical markers for the diagnosis and monitoring of Wilson disease Clin Biochem Rev 40 59-77
[2]
Weiss KH(2006)Wilson’s disease: an update Nat Clin Pract Neurol 2 482-493
[3]
Das SK(2012)EASL clinical practice guidelines: Wilson’s disease J Hepatol 56 671-685
[4]
Ray K(2018)Wtx101–an investigational drug for the treatment of Wilson disease Expert Opin Investig Drugs 27 561-567
[5]
Ferenci P(2005)Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice Clin Chem 51 1558-1559
[6]
Czlonkowska A(2008)Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories J Trace Elem Med Biol 22 50-53
[7]
Stremmel W(2009)Direct measurement of free copper in serum or plasma ultrafiltrate Am J Clin Pathol 131 160-165
[8]
Houwen R(2006)Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice J Clin Pathol 59 867-869
[9]
Rosenberg W(2009)Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects Anal Bioanal Chem 394 1477-1484
[10]
Schilsky M(2010)Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection Anal Chem 82 6904-6910